制药业呼吁开展全球合作,防治非传染性疾病,旨在每年节省数百万人。 Pharmaceutical industry calls for global cooperation to combat non-communicable diseases, aiming to save millions annually.

全球制药业正在敦促开展国际合作,以解决日益严重的非传染性疾病问题,这种疾病造成全球75%的死亡。 The global pharmaceutical industry is urging international cooperation to tackle the growing issue of non-communicable diseases (NCDs), which cause 75% of global deaths. 他们主张增加公共医疗保健支出,特别是针对非传染性疾病的支出,这在中低收入国家每年可挽救约500万人的生命。 They advocate for increased public healthcare spending, specifically targeting NCDs, which could save about 5 million lives annually in low- and middle-income countries. 该行业强调超过1 400种用于非传染性疾病的核定药品,并呼吁在联合国非传染性疾病问题会议召开之前,进行扶持性创新、投资和问责。 The industry highlights over 1,400 approved medicines for NCDs and calls for enabling innovation, investment, and accountability ahead of a UN meeting on NCDs.